Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2024 Jan 11;73(1):6-10.
doi: 10.15585/mmwr.mm7301a2.

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024

A Patricia Wodi, Neil Murthy, Veronica V McNally, Matthew F Daley, Sybil Cineas
Practice Guideline

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024

A Patricia Wodi et al. MMWR Morb Mortal Wkly Rep. .

Abstract

At its October 2023 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States, 2024. The child and adolescent immunization schedule, which can be found on the CDC immunization schedule website (https://www.cdc.gov/vaccines/schedules), is published annually to consolidate and summarize updates to ACIP recommendations on the vaccination of children and adolescents and to assist health care providers in implementing current ACIP recommendations. The 2024 immunization schedule includes several changes to the cover page, tables, notes, and appendix from the 2023 immunization schedule.† In addition, the 2024 child and adolescent immunization schedule includes a new addendum section to summarize new or updated ACIP recommendations that will occur before the next annual update to the child and adolescent immunization schedule. Health care providers are advised to use the cover page, tables, notes, appendix, and addendum together to identify the recommended immunizations for patient populations.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Veronica V. McNally reports that she is the president of the Franny Strong Foundation and that she received an honorarium for presenting to the Michigan Vaccine Project on May 23, 2023. No other potential conflicts of interest were disclosed.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. CDC. Charter of the Advisory Committee on Immunization Practices. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/vaccines/acip/committee/acip-charter.pdf
    1. CDC. ACIP Evidence to Recommendations Framework. Atlanta, GA: US Department of Health and Human services, CDC; 2023. https://www.cdc.gov/vaccines/acip/recs/grade/downloads/acip-evidence-rec...
    1. Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2023–24 influenza season. MMWR Recomm Rep 2023;72(No. RR-2):1–25. 10.15585/mmwr.rr7202a1 - DOI - PMC - PubMed
    1. ACIP updates: recommendations for use of 20-valent pneumococcal conjugate vaccine in children—United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:1072.10.15585/mmwr.mm7239a5 - DOI - PMC - PubMed
    1. Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices—United States, 2023. MMWR Morb Mortal Wkly Rep 2023;72:920–5. 10.15585/mmwr.mm7234a4 - DOI - PMC - PubMed

Publication types